
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0581 | -8.41906970004 | 0.6901 | 0.7494 | 0.62 | 47252 | 0.67540645 | CS |
4 | -0.1471 | -18.8807598511 | 0.7791 | 0.8437 | 0.62 | 50727 | 0.7225851 | CS |
12 | -0.318 | -33.4736842105 | 0.95 | 1.0799 | 0.62 | 68295 | 0.84354779 | CS |
26 | -0.538 | -45.9829059829 | 1.17 | 1.2401 | 0.62 | 72847 | 0.97924246 | CS |
52 | -1.128 | -64.0909090909 | 1.76 | 3.46 | 0.62 | 477872 | 2.49112372 | CS |
156 | -9.208 | -93.5772357724 | 9.84 | 15.89 | 0.62 | 228642 | 3.4731902 | CS |
260 | -14.288 | -95.764075067 | 14.92 | 25.78 | 0.62 | 205831 | 4.33655754 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.